TrialPath
← All studies
Obesity / overweight

Impact of Supplemental Fiber on Gut and Vascular Health Related in Obesity Phenotypes

Recruiting · Muncie, Indiana

Always free

Study care at no cost to you

For your time and travel

Many studies pay you back

Most need no insurance or papers

Legal status usually isn't required; we'll tell you each study's requirements

Interpreters available

Ask for your language

Your choice

Voluntary — you can stop anytime

What is this study?

Based on prior research, the investigators are interested in whether an intervention targeting gut health (supplemental fiber for 9 weeks total) will improve vascular health in individuals with obesity. Additionally, the investigators are interested in if this response differs based on whether individuals with obesity have very few heart disease risk factors or several heart disease risk factors.

It is , overseen by an independent and licensed medical staff.

Read the full clinical description

Based on prior research, the investigators are interested in whether an intervention targeting gut health (supplemental fiber for 9 weeks total) will improve vascular health in individuals with obesity. Additionally, the investigators are interested in if this response differs based on whether individuals with obesity have very few heart disease risk factors or several heart disease risk factors.

Who this study is looking for

In plain language, from the study's own rules. The study team confirms the full details with you — this isn't a final yes or no.

✅ You may be able to join if…

  • Adults ages 18 to 55
  • Have obesity (BMI 30 kg/m² or higher)
  • Have either 0–1 or 2+ heart risk factors that are outside normal ranges (blood pressure, blood sugar, triglycerides, and HDL-cholesterol)
  • Are not pregnant/expecting pregnancy (for females only) and are not postmenopausal (for females only)
  • Are able to lie on their back in a dark room for at least 10 minutes for vascular measurements

🚫 You may not be able to join if…

  • Under age 18 or over age 55
  • BMI is below 30 kg/m²
  • Are pregnant/expecting pregnancy (for females only) or are postmenopausal (for females only)
  • Have an advanced cardiometabolic condition (examples given: cardiovascular disease or type 2 diabetes)
  • Use tobacco/illicit drugs, take weight-loss medicines (examples given: Ozempic, Wegovy), or have a pacemaker

Are you a good fit?

Simplified highlights. The study team always confirms the full details with you.

  • Adults roughly 18–55
  • A BMI around 30 or higher
  • Have Obesity / overweight or Type 2 diabetes or Heart / cardiovascular disease or Rheumatoid arthritis or Crohn's / ulcerative colitis (IBD)
  • !Not for people who are pregnant or breastfeeding
  • !May require a break from current GLP-1 medications

What to expect, step by step

  1. 1

    Usually a few weeks

    The study team checks whether the study is a good fit for you, with a visit and sometimes lab tests. You can ask any questions before deciding.

  2. 2

    Treatment

    If you join and choose to continue, you receive the study treatment and are watched closely by medical staff.

  3. 3

    Follow-up

    After treatment, the team checks on your health and confirms the visit schedule with you. You can leave the study at any point.

Has this treatment been tested before?

The study team can share what safety testing has been done so far.

What you need to know before you apply

What is this study testing?+

Based on prior research, the investigators are interested in whether an intervention targeting gut health (supplemental fiber for 9 weeks total) will improve vascular health in individuals with obesity. Additionally, the investigators are interested in if this response differs based on whether individuals with obesity have very few heart disease risk factors or several heart disease risk factors.

Is it safe? Who makes sure of that?+

This is a research study. Every study is reviewed and monitored by an independent ethics board (called an IRB) whose job is to protect participants, and care is overseen by licensed medical staff. You'll be told the known risks before you agree to anything, and you can stop at any time.

Will I get a placebo instead of the real treatment?+

Some studies compare a treatment against a placebo (an inactive version), and some don't. If this one does, the study team will explain your chances of receiving the active treatment before you decide. Nothing is hidden from you.

I take a GLP-1 medication (like Ozempic or Wegovy). Can I still join?+

Maybe. This study may ask you to pause certain weight or diabetes medications for a period of time (a 'washout') before joining, or it may be looking for people not currently on them. The coordinator will review your medications with you — don't stop any medication on your own.

Does it cost anything? Will I be paid?+

Study-related care is provided at no cost to you. Some studies also pay for your time; the coordinator can tell you if this one does. You should never be asked to pay to take part.

Do I need insurance? Will anyone ask about my immigration status?+

No. You do not need health insurance to take part in a research study, and you will not be asked about your immigration status to join. Taking part is about whether you're a medical fit for the study.

What if English isn't my first language?+

You have the right to understand everything before you agree. Study sites can often provide materials or an interpreter in your language — you can ask the coordinator for one.

Is my information private?+

Yes. Your health information is only shared with the study sites you choose to be contacted by, and only to help match and enroll you. It is never sold, and you can ask us to delete it at any time.

Source: ClinicalTrials.gov · NCT07095426 · Locations: Indiana